Adrián Idoate-Bayón

Adrián Idoate-Bayón

Auto-generated profile, based on publicly available information

Adrián Idoate-Bayón

Diabetes Cure Research Association (DCRA), Villava, Navarra, Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2024 in Journal of Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
MBMiguel Burgos
Miguel Burgos
EGEva Gil-Iturbe
Eva Gil-Iturbe
AIAdrián Idoate-Bayón
Adrián Idoate-Bayón
RCRosa Castilla-Madrigal
Rosa Castilla-Madrigal
MMMaria J. Moreno-Aliaga
Maria J. Moreno-Aliaga
MLMaria Pilar Lostao
Maria Pilar Lostao
Obesity constitutes a global health epidemic which worsens the main leading death causes such as type 2 diabetes, cardiovascular diseases, and cancer. Changes in the metabolism in patients with obesity frequently lead to insulin resistance, along with hyperglycemia, dyslipidemia and low-grade inflammation, favoring a more aggressive tumor microenvironment. One of the hallmarks of cancer is the reprogramming of the energy metabolism, in which tumor cells change oxidative phosphorylation to aerobic glycolysis or “Warburg effect”. Aerobic glycolysis is faster than oxidative phosphorylation, but less efficient in terms of ATP production. To obtain sufficient ATP, tumor cells increase glucose uptake by the glucose transporters of the GLUT/SLC2 family. The human glucose transporter GLUT12 was isolated from the breast cancer cell line MCF7. It is expressed in adipose tissue, skeletal muscle and small intestine, where insulin promotes its translocation to the plasma membrane. Moreover, GLUT12 over‐expression in mice increases the whole‐body insulin sensitivity. Thus, GLUT12 has been proposed as a second insulin‐responsive glucose transporter. In obesity, GLUT12 is downregulated and does not respond to insulin. In contrast, GLUT12 is overexpressed in human solid tumors such as breast, prostate, gastric, liver and colon. High glucose concentration, insulin, and hypoxia upregulate GLUT12 both in adipocytes and tumor cells. Inhibition of GLUT12 mediated Warburg effect suppresses proliferation, migration, and invasion of cancer cells and xenografted tumors. This review summarizes the up-to-date information about GLUT12 physiological role and its implication in obesity and cancer, opening new perspectives to consider this transporter as a therapeutic target.

1 September 2020 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
EGEva Gil-Iturbe
Eva Gil-Iturbe
EFElisa Félix-Soriano
Elisa Félix-Soriano
NSNeira Sáinz
Neira Sáinz
AIAdrián Idoate-Bayón
Adrián Idoate-Bayón
RCRosa Castilla-Madrigal
Rosa Castilla-Madrigal
MLMaria Pilar Lostao
Maria Pilar Lostao
Obesity is characterized by excessive fat accumulation and inflammation. Aging has also been characterized as an inflammatory condition, frequently accompanied by accumulation of visceral fat. Beneficial effects of exercise and n-3 long-chain polyunsaturated fatty acids in metabolic disorders have been described. Glucose transporter 12 (GLUT12) is one of the less investigated members of the GLUT family. Glucose, insulin, and tumor necrosis factor alpha (TNF-α) induce GLUT12 translocation to the membrane in muscle, adipose tissue, and intestine. We aimed to investigate GLUT12 expression in obesity and aging, and under diet supplementation with docosahexaenoic acid (DHA) alone or in combination with physical exercise in mice. Aging increased GLUT12 expression in intestine, kidney, and adipose tissue, whereas obesity reduced it. No changes on the transporter occurred in skeletal muscle. In obese 18-month-old mice, DHA further decreased GLUT12 in the 4 organs. Aerobic exercise alone did not modify GLUT12, but the changes triggered by exercise were able to prevent the DHA-diminishing effect, and almost restored GLUT12 basal levels. In conclusion, the downregulation of metabolism in aging would be a stimulus to upregulate GLUT12 expression. Contrary, obesity, an excessive energy condition, would induce GLUT12 downregulation. The combination of exercise and DHA would contribute to restore basal function of GLUT12. Novelty In small intestine, kidney and adipose tissue aging increases GLUT12 protein expression whereas obesity reduces it. Dietary DHA decreases GLUT12 in small intestine, kidney, adipose tissue and skeletal muscle. Exercise alone does not modify GLUT12 expression, nevertheless exercise prevents the DHA-diminishing effect on GLUT12.

Verified
Journal Article
Open access
PDF file
JAJuan Añón-Hidalgo
Juan Añón-Hidalgo
Victoria CatalánVictoria Catalán
Victoria Catalán
ARAmaia Rodríguez
Amaia Rodríguez
BRBeatriz Ramírez
Beatriz Ramírez
AIAdrián Idoate-Bayón
Adrián Idoate-Bayón
Javier Gomez-AmbrosiJavier Gomez-Ambrosi
Javier Gomez-Ambrosi
Growth differentiation factor 11 (GDF11) is a member of the transforming growth factor (TGF)-β superfamily which declines with age and has been proposed as an anti-aging factor with regenerative effects in skeletal muscle in mice. However, recent data in humans and mice are conflicting, casting doubts about its true functional actions. The aim of the present study was to analyze the potential involvement of GFD11 in energy homeostasis in particular in relation with thyroid hormones. Serum concentrations of GDF11 were measured by enzyme-linked immunosorbent assay (ELISA) in 287 subjects. A highly significant positive correlation was found between GDF11 and thyroid-stimulating hormone (TSH) concentrations (r = 0.40, p < 0.001). Neither resting energy expenditure (REE) nor REE per unit of fat-free mass (REE/FFM) were significantly correlated (p > 0.05 for both) with GDF11 levels. In a multiple linear regression analysis, the model that best predicted logGDF11 included logTSH, leptin, body mass index (BMI), age, and C-reactive protein (logCRP). This model explained 37% of the total variability of logGDF11 concentrations (p < 0.001), with only logTSH being a significant predictor of logGDF11. After segregating subjects by TSH levels, those within the low TSH group exhibited significantly decreased (p < 0.05) GDF11 concentrations as compared to the normal TSH group or the high TSH group. A significant correlation of GDF11 levels with logCRP (r = 0.19, p = 0.025) was found. GDF11 levels were not related to the presence of hypertension or cardiopathy. In conclusion, our results show that circulating concentrations of GDF11 are closely associated with TSH concentrations and reduced in subjects with low TSH levels. However, GDF11 is not related to the regulation of energy expenditure. Our data also suggest that GDF11 may be involved in the regulation of inflammation, without relation to cardiac function. Further research is needed to elucidate the role of GDF11 in metabolism and its potential involvement in thyroid pathophysiology.

25 March 2026 in Journal of Endocrinological Investigation
Verified
Journal Article
Open access
PDF file
AIAdrián Idoate-Bayón
Adrián Idoate-Bayón
EAElena Ainzúa
Elena Ainzúa
JMJavier Marqués
Javier Marqués
Background: The Langerhans islets are highly vascularized structures that regulate plasma glucose levels. These islets are primarily composed of different types of endocrine cells (α, β, δ, PP, and ε) and endothelial cells. The paracrine signalling between pancreatic β-cells and endothelial cells is key for maintaining β-cell mass and preserving endocrine function. Oxidative stress, caused by an excess of reactive oxygen species (ROS), is a pathological mechanism that damages pancreatic β-cells and endothelial cells. Aim: In this review, we discuss how oxidative stress impacts not only on endothelial and pancreatic β-cells individually, but also on their paracrine signalling. Results: Oxidative stress triggers apoptosis and dysfunction of endothelial and pancreatic β-cells, as well as it alters glucose-stimulated insulin secretion (GSIS) from pancreatic β-cells. Moreover, oxidative stress affects to the homeostasis of vascular endothelial growth factor (VEGF) and Heparin-binding Epidermal Growth Factor (HB-EGF), two key mediators of the β-cell-endothelial cell crosstalk. Finally, an oxidative environment in the Langerhans islets promotes inflammation by increasing the secretion of cytokines, which impact in both cell types, further impairing insulin production. Conclusion: These effects of oxidative stress on the endothelial cell-β-cell paracrine signalling may represent a promising therapeutic target to alleviate diabetes development and its derived complications.

24 June 2026 in Nutrition
Verified
Journal Article
Closed access
AIAdrián Idoate-Bayón
Adrián Idoate-Bayón
BGBarbara Gómez-Taylor
Barbara Gómez-Taylor
Jorge Casaña MohedoJorge Casaña Mohedo
Jorge Casaña Mohedo
FCFrancisca Esteve Claramunt
Francisca Esteve Claramunt
MVMiryam Vacas-Cortés
Miryam Vacas-Cortés
Elena SandriElena Sandri
Elena Sandri